Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

TTFields and Pulsed Bevacizumab for Recurrent Glioblastoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02663271
Recruitment Status : Terminated (stagnant enrollment)
First Posted : January 26, 2016
Last Update Posted : August 11, 2021
NovoCure Ltd.
Information provided by (Responsible Party):
University of Florida

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : June 11, 2021
Actual Study Completion Date : June 11, 2021